Search
for
Sort by
Research 91–120 of 227
- Severe cutaneous adverse reactions to drugs
- THE PATHOGENESIS OF ALOPECIA AREATA
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Acne and Systemic Disease
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Recent advances in microneedle composites for biomedical applications: Advanced drug delivery technologies
- Essential syphilitic alopecia revisited
- The Basic Science of Hair Biology
- iNKT cells ameliorate human autoimmunity: Lessons from alopecia areata
- Field Cancerization: From Molecular Basis to Selective Field-Directed Management of Actinic Keratosis
- Therapeutic applications and pharmacoeconomics of microneedle technology
- Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims
- Kawasaki disease: an update
- REVIEW OF SO-CALLED ASEPTIC NEUTROPHILIC DERMATOSES
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Experiences From a Combined Dermatology and Rheumatology Clinic
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- ‘Disappearing Foot Disease’: An Unusual Presentation of Primary Lymphoma of Bone
- Clinical Profile of Methotrexate-resistant Juvenile Localised Scleroderma
- Approach to Patients with Suspected Rheumatic Disease
- Non‐infective mucocutaneous presentations of human immunodeficiency virus infection
- Does Inhibition of Aldose Reductase Contribute to the Anti-Inflammatory Action of Setipiprant?
- To evaluate the role of interleukin-6 in alopecia areata
- The spectrum of nephrocutaneous diseases and associations
- Significance of iron status in hair loss in women
- Immunosuppressive therapy in autoimmune disease — A review
- A Cell Membrane-Level Approach to Cicatricial Alopecia Management: Is Caveolin-1 a Viable Therapeutic Target in Frontal Fibrosing Alopecia?
- Ottawa, Ontario, Canada, February 13–16, 2013
- Footprints of the EADV: a meeting report from the 17th Congress of the European Academy of Dermatology and Venereology